AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Peerbridge Health, Inc · NCT06699056
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 8
- Study start
- November 21, 2024
- Record last updated
- June 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This prospective, multicenter, cluster-randomized controlled study aims to evaluate the accuracy of an investigational artificial intelligence (AI) Software as a Medical Device (SaMD) designed to compute ejection fraction (EF) severity categories based on the American Society of Echocardiography's (ASE) 4-category scale. The software analyzes continuous ECG waveform data acquired by the FDA-cleared Peerbridge COR® ECG Wearable Monitor, an ambulatory patch device designed for use during daily activities. The AI software assists clinicians in cardiac evaluations by estimating EF severity, which reflects how well the heart pumps blood.
In this study, EF severity determination will be made using 5-minute ECG recordings collected during a 15-minute resting period with participants seated upright. The results will be compared to EF severity obtained from an FDA-cleared, non-contrast transthoracic echocardiogram (TTE) predicate device. This comparison aims to validate the accuracy of the AI software.
Being studied: 15-minutes of sitting during COR ECG Acquistion
Conditions: Ventricular Ejection Fraction; LVF; LV Dysfunction; Atrial Enlargement; Conduction Defect; Heart Failure; Valvular Heart Disease; Ischemic Heart Disease; Cardiotoxicity; Myocardial Infarction; Dilated Cardiomyopathy; HFrEF - Heart Failure With Reduced Ejection Fraction; HFpEF - Heart Failure With Preserved Ejection Fraction; Syncope; Remodeling, Cardiac
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 18 years
- Able and eligible to wear a Holter monitor
Exclusion Criteria
- Receiving mechanical respiratory or circulatory support, or renal support therapy, at the time of screening or during Visit #1
- Any condition that, in the investigator's opinion, could interfere with compliance with the study protocol or pose a safety risk to the participant
- History of poor tolerance or severe skin reactions to ECG adhesive materials
Recruiting US locations
Orange County Heart Institute
Orange, CA 92868
Site contact: Brian Kolski, MD · (714) 564-3300 · bkolskimd@gmail.com
Peerbridge Health
Pasadena, CA 91107
Site contact: Sandeep Gulati, PhD · 877-960-0332 · s.gulati@peerbridgehealth.com
Henry Ford Hospital
Detroit, MI 48202
Site contact: Sacchin Parikh, MD · 313-916-2721 · Sparikh2@hfhs.org
Hackensack University Medical Center
Hackensack, NJ 07601
Site contact: Sameer Jamal, MD · 551-996-5870 · sameer.jamal@hmhn.org
Mount Sinai Hospital
New York, NY 10019
Site contact: Joslin J Plathottam, MBBS, MPH · 631-750-6345 · JoslinJose.Plathottam@mountsinai.org
Moses H. Cone Memorial Hospital
Greensboro, NC 27401
Site contact: Jennifer Knapp · 336-832-3795 · Jennifer.knapp@conehealth.com
Texas Cardiac Arrhythmia Research Foundation
Austin, TX 78705
Site contact: Andrea Natale, MD · 512-807-3150 · tcarfan@gmail.com
South Heart Clinic
Weslaco, TX 78596
Site contact: Frank Mazzola, MD · 877-426-7457 · frank.mazzola@southheartclinic.org
Study contacts (from the official record)
- Sandeep Gulati, PhD · 8182162958 · s.gulati@peerbridgehealth.com
- Chris Darland, MBA · 814-572-7138 · c.darland@peerbridgehealth.com
Similar studies in California
All heart & blood pressure studies in California →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Orange, CA + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Thomas Advanced Medical LLC
- Location
- Culver City, CA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Single-tracer Multiparametric PET Imaging
University of California, Davis
- Location
- Sacramento, CA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- San Diego, CA + 30 other US sites
- Eligibility basics
- Ages 65+